Press Releases< /span>
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Feb 20, 2008
- Fourth quarter and year end financial results to be released on February 27, 2008 - Toronto Stock Exchange Symbol: DND MISSISSAUGA, ON, Feb. 20 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: DND),...
-
Feb 11, 2008
Cipher Pharmaceuticals Inc. (TSX: DND) today announced that the U.S. Food and Drug Administration (FDA) has suggested an additional statistical sensitivity analysis of existing clinical data on...
-
Feb 1, 2008
Cipher Pharmaceuticals Inc. (TSX: DND) today announced that it has received a written response from the U.S. Food and Drug Administration (FDA) regarding its appeal of the Agency's Approvable...
-
Jan 8, 2008
Cipher Pharmaceuticals Inc. (TSX: DND), an emerging specialty pharmaceutical company, today provided an update on recent developments with its products. CIP-ISOTRETINOIN In June 2007, Cipher...
-
Dec 5, 2007
Cipher Pharmaceuticals Inc. (TSX: DND) today announced that Dr. Stefan Aigner, M.D., CFA, has been appointed to its Board of Directors. Dr. Aigner has more than 20 years of experience in the...